Author:
Maheshwari Shubhrat,Verma Amita,Singh Aditya,Wasim Rufaida,Shariq Mohammad,Akhtar Juber,Prajapati Bhupendra G.
Publisher
Springer Nature Singapore
Reference92 articles.
1. Singh AV, Khare M, Gade WN, Zamboni P (2012) Theranostic implications of nanotechnology in multiple sclerosis: a future perspective. Autoimmun Dis 2012(1):160830
2. Nuzzo D, Picone P (2021) Multiple sclerosis: focus on extracellular and artificial vesicles, nanoparticles as potential therapeutic approaches. Int J Mol Sci 22(16):8866
3. Zhang Q, Dai X, Zhang H, Zeng Y, Luo K, Li W (2021) Recent advances in development of nanomedicines for multiple sclerosis diagnosis. Biomed Mater 16(2):024101
4. Ghosh S, Bhatti GK, Sharma PK, Kandimalla R, Mastana SS, Bhatti JS (2024) Potential of nano-engineered stem cells in the treatment of multiple sclerosis: a comprehensive review. Cell Mol Neurobiol 44(1):6
5. Subhash S, Chaurawal N, Raza K (2024) Promises of lipid-based nanocarriers for delivery of dimethyl fumarate to multiple sclerosis brain. In: Neuroprotection: method and protocols. Springer US, New York, NY, pp 457–475